Oncolytic virotherapy with RIGVIR® is reimbursable medication

Oncolytic virotherapy with RIGVIR® is included in the list of reimbursable state-funded medical products in Latvia for skin melanoma patients.

Contacts for Media Inquiries

Rigvir Group
E-mail: pr@rigvir.com